Study Finds Seasonal Flu Vaccines May Boost Cross-Protective Immunity Against H5N1 Through Neuraminidase Antibodies
Researchers analyzed antibodies in 749 human serum samples collected over ten flu seasons and found that seasonal influenza vaccines can increase neuraminidase-inhibiting antibodies that cross-react with H5N1 viruses. Neuraminidase is a viral protein that has been historically overlooked in favor of hemagglutinin in vaccine design and immunity studies. The findings suggest that existing seasonal vaccines may provide some baseline protection against H5N1 and support reconsidering neuraminidase in pandemic preparedness strategies.
A retrospective analysis of human serum samples spanning pre- and post-2009 pandemic periods found detectable neuraminidase-inhibiting antibodies against three genotypes of clade 2.3.4.4b H5N1 viruses across all ten influenza seasons studied. Seasonal inactivated influenza vaccination was associated with a modest but reproducible increase in these cross-reactive antibodies, particularly from the 2009-2010 season onward when A(H1N1)pdm09 was introduced into seasonal vaccine formulations. In contrast, hemagglutinin-directed immunity against H5 remained generally low or undetectable despite detectable HA-reactive antibodies by ELISA. The study used enzyme-linked lectin assay (ELLA) to measure NA-inhibiting antibodies and luciferase-based microneutralization assays to assess neutralizing antibodies. These findings indicate that neuraminidase-specific immunity warrants greater attention in influenza serosurveillance and vaccine evaluation strategies.
What's missing
The study does not specify the demographic characteristics of the 749 individuals sampled, geographic distribution of samples, or whether results varied by age group or prior influenza exposure history. Additionally, the clinical significance of the modest increases in NA-inhibiting titers and their actual protective efficacy against H5N1 infection in humans remains to be determined.
What different sources said
- bioRxivCenter
Neuraminidase-Based Cross-Protective Immunity against H5N1 Influenza Viruses in Humans
Related
Multiscale Brain Model Predicts Novel Propofol Anesthesia Biomarker Without Training on Clinical Data
Researchers developed a mechanistic computational model of thalamocortical brain circuits that successfully predicted a previously unnoticed dose-dependent biomarker of propofol anesthesia. The model, driven solely by GABA-A receptor modulation, reproduced empirical data from both macaques and humans without being fitted to any anesthesia-specific data. The findings suggest that simulation-first approaches could accelerate biomarker discovery in neuropharmacology without requiring large clinical datasets.
Green-Synthesized Zinc Oxide Nanoparticles from Mimosa pudica Show Biocompatibility with Bone Marrow Stem Cells in Lab Study
Researchers synthesized zinc oxide nanoparticles using Mimosa pudica leaf extract and tested their effects on human bone marrow mesenchymal stromal cells, finding the nanoparticles preserved cell viability, structure, and bone-forming capacity. The plant-derived nanoparticles outperformed both the raw plant extract and conventionally synthesized zinc oxide in maintaining cell metabolic activity over five days. The findings suggest these bioactive nanomaterials could be candidates for musculoskeletal tissue engineering, though the research remains at an early in vitro stage.
Study Compares Genetic Modeling Approaches for Dyadic Social Interactions in Animals
A new preprint study compared two statistical modeling approaches for analyzing the genetic basis of social interactions in animals, finding that dyadic models outperform marginal models that aggregate individual-level data. The research used pig aggression data from 797 finishing pigs across 59 social groups as a test case. The findings have implications for how animal geneticists model and interpret the heritable components of social behavior.